معرفی
Michael Prentice is a Professor of Medical Microbiology at University College Cork (UCC), where he conducts groundbreaking research in bacterial genomics and microcompartment biology. He is a principal investigator at the Alimentary Pharmabiotic Centre (APC) and previously served as a Senior Lecturer at Bart's and the London Medical School, Queen Mary University of London from 1993-2004.
His educational background includes:
- MB ChB (Medical Degree) from Birmingham Medical School (UK) in 1980
- PhD from Queen Mary, University of London in 1998
- Professional qualifications: FRCP (2021), FRCPI (2020), FFPRCPI (2007), FRCPath (1999)
Professor Prentice's research centers on bacterial genomics, particularly Yersinia pestis and Yersinia enterocolitica genomes, and the role of horizontally transmitted genes in bacterial pathogenicity. His discovery of a horizontally-transferred metabolosome-specifying operon in Y. enterocolitica led to significant work on bacterial microcompartments (metabolosomes), which are present in approximately 20% of bacterial genomes. His research has shown these structures are important in E. coli urinary tract infections and has applications in renal failure complications and environmental bioremediation.
Analysis of his recent publications reveals a strong pivot toward practical applications of microbiological research, particularly in infection control during the pandemic. His 2020-2023 work addresses airborne transmission of SARS-CoV-2, hospital infection control measures, and aerosol dynamics in medical settings, demonstrating how his foundational expertise in bacterial metabolism and genomics informed critical pandemic response research.
His research has been supported by:
- Science Foundation Ireland (multiple awards totaling over €500,000 since 2012)
- Health Research Board
- Healthcare Infection Society
- Higher Education Authority
- Department of Agriculture, Food and the Marine (DAFF)
Professor Prentice has successfully supervised numerous graduate students including Karen McCarthy (PhD, 2016), Alan Barry (MSc, 2015), Tamara Ringwood (PhD, 2013), Kamila Knapik (PhD, 2013), and Olabisi Ojo (PhD, 2009). His laboratory has received continuous funding for innovative research bridging basic science and clinical applications.
He maintains extensive collaborations with researchers at UCC (Dr. John MacSharry, Professor Barry Plant), University of Kent (Professor Martin Warren), Queen Mary University of London (Professor Richard Pickersgill), and international institutions including University of Versailles. His work with the APC positions him at the forefront of microbiome research in Ireland, with particular emphasis on the intersection of bacterial metabolism and human health.
